Your browser doesn't support javascript.
loading
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
Bortolini Silveira, Amanda; Bidard, François-Clément; Tanguy, Marie-Laure; Girard, Elodie; Trédan, Olivier; Dubot, Coraline; Jacot, William; Goncalves, Anthony; Debled, Marc; Levy, Christelle; Ferrero, Jean-Marc; Jouannaud, Christelle; Rios, Maria; Mouret-Reynier, Marie-Ange; Dalenc, Florence; Hego, Caroline; Rampanou, Aurore; Albaud, Benoit; Baulande, Sylvain; Berger, Frédérique; Lemonnier, Jérôme; Renault, Shufang; Desmoulins, Isabelle; Proudhon, Charlotte; Pierga, Jean-Yves.
Afiliação
  • Bortolini Silveira A; Circulating Tumor Biomarkers laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France.
  • Bidard FC; Circulating Tumor Biomarkers laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France.
  • Tanguy ML; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, Paris, France.
  • Girard E; UVSQ, Université Paris-Saclay, Paris, France.
  • Trédan O; Department of Biostatistics, Institut Curie, Paris, France.
  • Dubot C; INSERM U900, Institut Curie, Mines ParisTech, PSL Research University, Paris, France.
  • Jacot W; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Goncalves A; Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, Paris, France.
  • Debled M; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, IRCM INSERM, Montpellier, France.
  • Levy C; Department of Medical Oncology, Aix-Marseille Univ, INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, CRCM, Marseille, France.
  • Ferrero JM; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Jouannaud C; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Rios M; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Mouret-Reynier MA; Department of Medical Oncology, Institut Jean Godinot, Reims, France.
  • Dalenc F; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-Lès-Nancy, France.
  • Hego C; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
  • Rampanou A; Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Albaud B; Circulating Tumor Biomarkers laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France.
  • Baulande S; Circulating Tumor Biomarkers laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France.
  • Berger F; ICGex Next-Generation Sequencing Platform, Institut Curie, Paris, France.
  • Lemonnier J; ICGex Next-Generation Sequencing Platform, Institut Curie, Paris, France.
  • Renault S; Department of Biostatistics, Institut Curie, Paris, France.
  • Desmoulins I; R&D UNICANCER, UCBG, Paris, France.
  • Proudhon C; Circulating Tumor Biomarkers laboratory, INSERM CIC BT-1428, Institut Curie, Paris, France.
  • Pierga JY; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
NPJ Breast Cancer ; 7(1): 115, 2021 Sep 09.
Article em En | MEDLINE | ID: mdl-34504096
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article